{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:09Z","timestamp":1772165709033,"version":"3.50.1"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuromuscular diseases (NMD) emerged as one of the main side effects of the COVID-19 vaccination. We pooled and summarized the evidence on the clinical features and outcomes of NMD associated with COVID-19 vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We comprehensively searched three databases, Medline, Embase, and Scopus, using the key terms covering \u201cNeuromuscular disease\u201d AND \u201cCOVID-19 vaccine\u201d, and pooled the individual patient data extracted from the included studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 258 NMD cases following COVID-19 have been reported globally, of which 171 cases were Guillain-Barr\u00e9 syndrome (GBS), 40 Parsonage-Turner syndrome (PTS), 22 Myasthenia Gravis (MG), 19 facial nerve palsy (FNP), 5 single fiber neuropathy, and 1 Tolosa-Hunt syndrome. All (100%) SFN patients and 58% of FNP patients were female; in the remaining NMDs, patients were predominantly male, including MG (82%), GBS (63%), and PTS (62.5%).<\/jats:p>\n                    <jats:p>The median time from vaccine to symptom was less than 2\u2009weeks in all groups. Symptoms mainly appeared following the first dose of vector vaccine, but there was no specific pattern for mRNA-based.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COVID-19 vaccines might induce some NMDs, mainly in adults. The age distribution and gender characteristics of affected patients may differ based on the NMD type. About two-thirds of the cases probably occur less than 2 weeks after vaccination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-023-03486-y","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T04:02:29Z","timestamp":1702267349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Amirhossein","family":"Tayebi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parham","family":"Samimisedeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmira","family":"Jafari Afshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh","family":"Mahmoudnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesa","family":"Milan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryan","family":"Ayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryan","family":"Madady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadith","family":"Rastad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"3486_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S1473-3099(22)00414-5","volume":"22","author":"AR Mariatulqabtiah","year":"2022","unstructured":"Mariatulqabtiah AR, Buttigieg KR. COVID-19 vaccinations for children. Lancet Infect Dis. 2022;22:1255\u20136.","journal-title":"Lancet Infect Dis."},{"key":"3486_CR2","volume-title":"Coronavirus pandemic (COVID-19)","author":"E Mathieu","year":"2020","unstructured":"Mathieu E, et al. Coronavirus pandemic (COVID-19). Our World Data; 2020."},{"key":"3486_CR3","doi-asserted-by":"publisher","first-page":"733418","DOI":"10.3389\/fimmu.2021.733418","volume":"12","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zhou R, Yang H, Yang H. To be or not to be vaccinated: that is a question in myasthenia gravis. Front Immunol. 2021;12:733418.","journal-title":"Front Immunol."},{"key":"3486_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/jmri.28268","volume":"56","author":"P Samimisedeh","year":"2022","unstructured":"Samimisedeh P, Jafari Afshar E, Shafiabadi Hassani N, Rastad H. Cardiac MRI findings in COVID-19 vaccine-related myocarditis: A pooled analysis of 468 patients. J Magn Reson Imaging. 2022;56:971\u201382.","journal-title":"J Magn Reson Imaging."},{"key":"3486_CR5","doi-asserted-by":"publisher","first-page":"e6505","DOI":"10.1002\/ccr3.6505","volume":"10","author":"A Haj Mohamad Ebrahim Ketabforoush","year":"2022","unstructured":"Haj Mohamad Ebrahim Ketabforoush A, Molaverdi G, Nirouei M, Abbasi Khoshsirat N. Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID-19 AstraZeneca vaccination: A case report. Clin Case Rep. 2022;10:e6505.","journal-title":"Clin Case Rep."},{"key":"3486_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jns.12482","volume":"27","author":"A Taga","year":"2022","unstructured":"Taga A, Lauria G. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst JPNS. 2022;27:4\u201330.","journal-title":"J Peripher Nerv Syst JPNS."},{"key":"3486_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10072-021-05662-9","volume":"43","author":"RK Garg","year":"2022","unstructured":"Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43:3\u201340.","journal-title":"Neurol Sci."},{"key":"3486_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines. 2021;9:435.","journal-title":"Vaccines."},{"key":"3486_CR9","first-page":"5009450","volume":"2022","author":"O Mirmosayyeb","year":"2022","unstructured":"Mirmosayyeb O, et al. Is myasthenia gravis a real complication of the COVID-19 vaccine? A case report-based systematic review. Can J Infect Dis Med Microbiol J Can Mal Infect Microbiol Medicale. 2022;2022:5009450.","journal-title":"Can J Infect Dis Med Microbiol J Can Mal Infect Microbiol Medicale."},{"key":"3486_CR10","doi-asserted-by":"publisher","first-page":"107562","DOI":"10.1016\/j.ijscr.2022.107562","volume":"98","author":"R Zargarbashi","year":"2022","unstructured":"Zargarbashi R, Vosoughi F, Milan N. Wide resection as a solution to excruciating pain in intraneural hemangioma: follow-up of a previously published case report. Int J Surg Case Rep. 2022;98:107562.","journal-title":"Int J Surg Case Rep."},{"key":"3486_CR11","doi-asserted-by":"publisher","first-page":"e34890","DOI":"10.1097\/MD.0000000000034890","volume":"102","author":"AH Tayebi","year":"2023","unstructured":"Tayebi AH, et al. Clinical features and outcomes of myasthenia gravis associated with COVID-19 vaccines: A systematic review and pooled analysis. Medicine (Baltimore). 2023;102:e34890.","journal-title":"Medicine (Baltimore)."},{"issue":"10","key":"3486_CR12","first-page":"2127","volume":"18","author":"Z Munn","year":"2019","unstructured":"Munn Z, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synthesis. 2019;18(10):2127\u201333.","journal-title":"JBI Evid Synthesis."},{"key":"3486_CR13","doi-asserted-by":"publisher","first-page":"e29333","DOI":"10.1097\/MD.0000000000029333","volume":"101","author":"AR Siddiqi","year":"2022","unstructured":"Siddiqi AR, et al. Miller fisher syndrome after COVID-19 vaccination: case report and review of literature. Medicine (Baltimore). 2022;101:e29333.","journal-title":"Medicine (Baltimore)."},{"key":"3486_CR14","doi-asserted-by":"publisher","first-page":"e935275","DOI":"10.12659\/AJCR.935275","volume":"23","author":"HL Thant","year":"2022","unstructured":"Thant HL, et al. Guillain-Barr\u00e9 syndrome after Ad26.COV2.S vaccination. Am J Case Rep. 2022;23:e935275.","journal-title":"Am J Case Rep."},{"key":"3486_CR15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s13760-021-01838-4","volume":"122","author":"FG Masuccio","year":"2022","unstructured":"Masuccio FG, Comi C, Solaro C. Guillain-Barr\u00e8 syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurol Belg. 2022;122:1369\u201371.","journal-title":"Acta Neurol Belg"},{"key":"3486_CR16","first-page":"1","volume":"2021","author":"J Finsterer","year":"2021","unstructured":"Finsterer J. Exacerbating Guillain\u2013Barr\u00e9 Syndrome Eight Days after Vector-Based COVID-19 Vaccination. Case Rep Infect Dis. 2021;2021:1\u20133.","journal-title":"Case Rep Infect Dis."},{"key":"3486_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10072-021-05776-0","volume":"43","author":"A Abi\u010di\u0107","year":"2022","unstructured":"Abi\u010di\u0107 A, Adamec I, Habek M. Miller fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci. 2022;43:1495\u20137.","journal-title":"Neurol Sci."},{"key":"3486_CR18","doi-asserted-by":"publisher","first-page":"e04756","DOI":"10.1002\/ccr3.4756","volume":"9","author":"AS Matarneh","year":"2021","unstructured":"Matarneh AS, Al-battah AH, Farooqui K, Ghamoodi M, Alhatou M. COVID-19 vaccine causing Guillain-Barre syndrome, a rare potential side effect. Clin Case Rep. 2021;9:e04756.","journal-title":"Clin Case Rep."},{"key":"3486_CR19","first-page":"852","volume":"19","author":"B Khadka","year":"2022","unstructured":"Khadka B, Khanal K. Post COVID-19 vaccine Guillain-Barr\u00e9 syndrome. J Nepal Health Res Counc. 2022;19:852\u20134.","journal-title":"J Nepal Health Res Counc."},{"key":"3486_CR20","doi-asserted-by":"publisher","first-page":"e244125","DOI":"10.1136\/bcr-2021-244125","volume":"14","author":"N McKean","year":"2021","unstructured":"McKean N, Chircop C. Guillain-Barr\u00e9 syndrome after COVID-19 vaccination. BMJ Case Rep. 2021;14:e244125.","journal-title":"BMJ Case Rep."},{"key":"3486_CR21","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1212\/WNL.0000000000011881","volume":"96","author":"AM Loza","year":"2021","unstructured":"Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: Temporal Associations Do Not Imply Causality. Neurology. 2021;96:1052\u20134.","journal-title":"Neurology."},{"key":"3486_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.12691\/ajmcr-9-8-10","volume":"9","author":"S Azam","year":"2021","unstructured":"Azam S, Khalil A, Taha A. Guillain-Barr\u00e9 syndrome in a 67-year-old male post COVID-19 vaccination (Astra Zeneca). Am J Med Case Rep. 2021;9:424\u20137.","journal-title":"Am J Med Case Rep."},{"key":"3486_CR23","first-page":"e22341","volume":"14","author":"AS Zubair","year":"2022","unstructured":"Zubair AS, Bae JY, Desai K. Facial Diplegia variant of Guillain-Barr\u00e9 syndrome in pregnancy following COVID-19 vaccination: A case report. Cureus. 2022;14:e22341.","journal-title":"Cureus."},{"key":"3486_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/CND.0000000000000376","volume":"23","author":"NM Michaelson","year":"2021","unstructured":"Michaelson NM, Lam T, Malhotra A, Schiff ND, MacGowan DJL. Miller fisher syndrome presenting after a second dose of Pfizer-BioNTech vaccination in a patient with resolved COVID-19: A case report. J Clin Neuromuscul Dis. 2021;23:113\u20135.","journal-title":"J Clin Neuromuscul Dis."},{"key":"3486_CR25","doi-asserted-by":"publisher","first-page":"e32140","DOI":"10.1097\/MD.0000000000032140","volume":"101","author":"BW Hwang","year":"2022","unstructured":"Hwang BW, Bong JB. Two possible etiologies of Guillain-Barr\u00e9 syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report. Medicine (Baltimore). 2022;101:e32140.","journal-title":"Medicine (Baltimore)."},{"key":"3486_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10072-021-05733-x","volume":"43","author":"N Bouattour","year":"2022","unstructured":"Bouattour N, et al. Guillain-Barr\u00e9 syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurol Sci. 2022;43:755\u201361.","journal-title":"Neurol Sci."},{"key":"3486_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/neurolint13030040","volume":"13","author":"A Prasad","year":"2021","unstructured":"Prasad A, et al. A novel case of bifacial Diplegia variant of Guillain-Barr\u00e9 syndrome following Janssen COVID-19 vaccination. Neurol Int. 2021;13:404\u20139.","journal-title":"Neurol Int."},{"key":"3486_CR28","first-page":"e18153","volume":"13","author":"ZP Morehouse","year":"2021","unstructured":"Morehouse ZP, Paulus A, Jasti SA, Bing X. A rare variant of Guillain-Barre syndrome following Ad26.COV2.S vaccination. Cureus. 2021;13:e18153.","journal-title":"Cureus."},{"key":"3486_CR29","first-page":"e28044","volume":"14","author":"U Ilyas","year":"2022","unstructured":"Ilyas U, Umar Z, Bhangal R, Shah D, Fayman B. Guillain-Barr\u00e9 syndrome: A sequela of the original COVID-19 infection or vaccination. Cureus. 2022;14:e28044.","journal-title":"Cureus."},{"key":"3486_CR30","doi-asserted-by":"publisher","first-page":"e246701","DOI":"10.1136\/bcr-2021-246701","volume":"14","author":"YL Dang","year":"2021","unstructured":"Dang YL, Bryson A. Miller-fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep. 2021;14:e246701.","journal-title":"BMJ Case Rep."},{"key":"3486_CR31","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1007\/s10072-021-05467-w","volume":"42","author":"NA Nasuelli","year":"2021","unstructured":"Nasuelli NA, et al. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci. 2021;42:4747\u20139.","journal-title":"Neurol Sci."},{"key":"3486_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/cen3.12678","volume":"13","author":"GF da Silva","year":"2022","unstructured":"da Silva GF, et al. Guillain-Barr\u00e9 syndrome after coronavirus disease 2019 vaccine: A temporal association. Clin Exp Neuroimmunol. 2022;13:92\u20134.","journal-title":"Clin Exp Neuroimmunol."},{"key":"3486_CR33","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.jemermed.2021.07.062","volume":"61","author":"A Rossetti","year":"2021","unstructured":"Rossetti A, Gheihman G, O\u2019Hare M, Kosowsky JM. Guillain-Barr\u00e9 syndrome presenting as facial Diplegia after COVID-19 vaccination: A case report. J Emerg Med. 2021;61:e141\u20135.","journal-title":"J Emerg Med."},{"key":"3486_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12883-021-02489-x","volume":"21","author":"Y Nishiguchi","year":"2021","unstructured":"Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol. 2021;21:452.","journal-title":"BMC Neurol"},{"key":"3486_CR35","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1080\/21645515.2021.1954826","volume":"17","author":"R Scendoni","year":"2021","unstructured":"Scendoni R, Petrelli C, Scaloni G, Logullo FO. Electromyoneurography and laboratory findings in a case of Guillain-Barr\u00e9 syndrome after second dose of Pfizer COVID-19 vaccine. Hum Vaccines Immunother. 2021;17:4093\u20136.","journal-title":"Hum Vaccines Immunother."},{"key":"3486_CR36","doi-asserted-by":"publisher","first-page":"e01143","DOI":"10.1016\/j.idcr.2021.e01143","volume":"24","author":"O Ogbebor","year":"2021","unstructured":"Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: A temporal occurrence, not a causal association. IDCases. 2021;24:e01143.","journal-title":"IDCases"},{"key":"3486_CR37","first-page":"002707","volume":"8","author":"Y Kripalani","year":"2021","unstructured":"Kripalani Y, et al. A rare case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccination. Eur J Case RepIntern Med. 2021;8:002707.","journal-title":"Eur J Case RepIntern Med."},{"key":"3486_CR38","doi-asserted-by":"publisher","first-page":"e243629","DOI":"10.1136\/bcr-2021-243629","volume":"14","author":"T Hasan","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine. BMJ Case Rep. 2021;14:e243629.","journal-title":"BMJ Case Rep."},{"key":"3486_CR39","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1007\/s10072-021-05523-5","volume":"42","author":"M Trimboli","year":"2021","unstructured":"Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci. 2021;42:4401\u20132.","journal-title":"Neurol Sci."},{"key":"3486_CR40","doi-asserted-by":"publisher","first-page":"e242956","DOI":"10.1136\/bcr-2021-242956","volume":"14","author":"SU Patel","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021;14:e242956.","journal-title":"BMJ Case Rep."},{"key":"3486_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/19418744211065242","volume":"12","author":"TA Lanman","year":"2022","unstructured":"Lanman TA, Wu C, Cheung H, Goyal N, Greene M. Guillain-Barr\u00e9 syndrome with rapid onset and autonomic dysfunction following first dose of Pfizer-BioNTech COVID-19 vaccine: A case report. The Neurohospitalist. 2022;12:388\u201390.","journal-title":"The Neurohospitalist."},{"key":"3486_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/lt.26279","volume":"28","author":"DL Hughes","year":"2022","unstructured":"Hughes DL, et al. Guillain-Barr\u00e9 syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response. Liver Transpl. 2022;28:134\u20137.","journal-title":"Liver Transpl."},{"key":"3486_CR43","first-page":"286","volume":"74","author":"NK Tutar","year":"2021","unstructured":"Tutar NK, Eyig\u00fcrb\u00fcz T, Yildirim Z, Kale N. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Ideggyogyaszati Szle. 2021;74:286\u20138.","journal-title":"Ideggyogyaszati Szle."},{"key":"3486_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s42399-022-01124-1","volume":"4","author":"S Nagalli","year":"2022","unstructured":"Nagalli S, Shankar Kikkeri N. Sub-acute onset of Guillain-Barr\u00e9 syndrome post-mRNA-1273 vaccination: a case report. SN Compr Clin Med. 2022;4:41.","journal-title":"SN Compr Clin Med."},{"key":"3486_CR45","doi-asserted-by":"publisher","first-page":"106887","DOI":"10.1016\/j.clineuro.2021.106887","volume":"208","author":"A Introna","year":"2021","unstructured":"Introna A, et al. Guillain-Barr\u00e9 syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association? Clin Neurol Neurosurg. 2021;208:106887.","journal-title":"Clin Neurol Neurosurg."},{"key":"3486_CR46","first-page":"e13426","volume":"13","author":"S Waheed","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021;13:e13426.","journal-title":"Cureus."},{"key":"3486_CR47","doi-asserted-by":"publisher","unstructured":"Donaldson L, Margolin E. Variant Guillain-Barre syndrome following SARS-CoV-2 vaccination: case report and review of the literature. Can J Neurol Sci J Can Sci Neurol. 2022;1\u20133 https:\/\/doi.org\/10.1017\/cjn.2021.492.","DOI":"10.1017\/cjn.2021.492"},{"key":"3486_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12883-022-02838-4","volume":"22","author":"K Nanatsue","year":"2022","unstructured":"Nanatsue K, Takahashi M, Itaya S, Abe K, Inaba A. A case of miller fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report. BMC Neurol. 2022;22:309.","journal-title":"BMC Neurol."},{"key":"3486_CR49","doi-asserted-by":"publisher","unstructured":"Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial Diplegia: A rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26.COV2.S vaccine. Cureus. 2021; https:\/\/doi.org\/10.7759\/cureus.16612.","DOI":"10.7759\/cureus.16612"},{"key":"3486_CR50","doi-asserted-by":"publisher","first-page":"e05733","DOI":"10.1002\/ccr3.5733","volume":"10","author":"Z Anjum","year":"2022","unstructured":"Anjum Z, et al. Guillain-Barr\u00e9 syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: A case report. Clin Case Rep. 2022;10:e05733.","journal-title":"Clin Case Rep."},{"key":"3486_CR51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.9758\/cpn.2022.20.4.777","volume":"20","author":"PY Gunawan","year":"2022","unstructured":"Gunawan PY, Tiffani P, Lalisang L. Guillain-Barre syndrome following SARS-CoV-2 vaccination: A case report. Clin Psychopharmacol Neurosci. 2022;20:777\u201380.","journal-title":"Clin Psychopharmacol Neurosci."},{"key":"3486_CR52","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2169\/internalmedicine.8967-21","volume":"61","author":"S Ogata","year":"2022","unstructured":"Ogata S, et al. Sensory ataxic Guillain-Barr\u00e9 syndrome with Dysgeusia after mRNA COVID-19 vaccination. Intern Med Tokyo Jpn. 2022;61:1757\u201360.","journal-title":"Intern Med Tokyo Jpn."},{"key":"3486_CR53","doi-asserted-by":"publisher","first-page":"E1766","DOI":"10.1503\/cmaj.210947","volume":"193","author":"L Ling","year":"2021","unstructured":"Ling L, Bagshaw SM, Villeneuve P-M. Guillain-Barr\u00e9 syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barr\u00e9 syndrome. CMAJ Can Med Assoc J J Assoc Medicale Can. 2021;193:E1766\u20139.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can."},{"key":"3486_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5606\/tftrd.2022.9984","volume":"68","author":"H Bazrafshan","year":"2022","unstructured":"Bazrafshan H, Mohamadi Jahromi LS, Parvin R, Ashraf A. A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination. Turk J Phys Med Rehabil. 2022;68:295\u20139.","journal-title":"Turk J Phys Med Rehabil."},{"key":"3486_CR55","doi-asserted-by":"publisher","first-page":"e936896","DOI":"10.12659\/AJCR.936896","volume":"23","author":"A Hilts","year":"2022","unstructured":"Hilts A, Schreiber A, Singh A. A clinical case of COVID-19 vaccine-associated Guillain-Barr\u00e9 syndrome. Am J Case Rep. 2022;23:e936896.","journal-title":"Am J Case Rep."},{"key":"3486_CR56","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s13256-022-03592-4","volume":"16","author":"FJC Pirola","year":"2022","unstructured":"Pirola FJC, et al. Miller-fisher syndrome after first dose of Oxford\/AstraZeneca coronavirus disease 2019 vaccine: a case report. J Med Case Rep. 2022;16:437.","journal-title":"J Med Case Rep."},{"key":"3486_CR57","doi-asserted-by":"publisher","first-page":"894872","DOI":"10.3389\/fimmu.2022.894872","volume":"13","author":"M Bellucci","year":"2022","unstructured":"Bellucci M, et al. Case report: post-COVID-19 vaccine recurrence of Guillain-Barr\u00e9 syndrome following an antecedent Parainfectious COVID-19-related GBS. Front Immunol. 2022;13:894872.","journal-title":"Front Immunol."},{"key":"3486_CR58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/20009666.2021.1954284","volume":"11","author":"SJ Rao","year":"2021","unstructured":"Rao SJ, et al. A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine. J Community Hosp Intern Med Perspect. 2021;11:597\u2013600.","journal-title":"J Community Hosp Intern Med Perspect."},{"key":"3486_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pediatrneurol.2021.10.003","volume":"126","author":"E Malamud","year":"2022","unstructured":"Malamud E, Otallah SI, Caress JB, Lapid DJ. Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in an adolescent. Pediatr Neurol. 2022;126:9\u201310.","journal-title":"Pediatr Neurol"},{"key":"3486_CR60","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/19418744221097350","volume":"12","author":"MB Prado","year":"2022","unstructured":"Prado MB, Adiao KJB. Facial Diplegia as the sole manifestation of post-vaccination Guillain-Barre syndrome: A case report and literature review. The Neurohospitalist. 2022;12:508\u201311.","journal-title":"The Neurohospitalist."},{"key":"3486_CR61","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/01658107.2022.2048861","volume":"46","author":"J Richardson-May","year":"2022","unstructured":"Richardson-May J, Purcaru E, Campbell C, Hillier C, Parkin B. Guillain-Barr\u00e9 syndrome and unilateral optic neuritis following vaccination for COVID-19: A case report and literature review. Neuro-Ophthalmol Aeolus Press. 2022;46:413\u20139.","journal-title":"Neuro-Ophthalmol Aeolus Press."},{"key":"3486_CR62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.rce.2021.05.005","volume":"221","author":"IF Aomar-Mill\u00e1n","year":"2021","unstructured":"Aomar-Mill\u00e1n IF, Mart\u00ednez de Victoria-Carazo J, Peregrina-Rivas JA, Villegas-Rodr\u00edguez I. COVID-19, Guillain-Barr\u00e9 y vacuna. Una mezcla peligrosa. Rev Cl\u00ednica Esp. 2021;221:555\u20137.","journal-title":"Rev Cl\u00ednica Esp."},{"key":"3486_CR63","doi-asserted-by":"publisher","first-page":"183","DOI":"10.14712\/18059694.2021.31","volume":"64","author":"D \u010cen\u0161\u010d\u00e1k","year":"2021","unstructured":"\u010cen\u0161\u010d\u00e1k D, Ungermann L, \u0160t\u011btk\u00e1\u0159ov\u00e1 I, Ehler E. Guillan-Barr\u00e9 syndrome after first vaccination dose against COVID-19: case report. Acta Med (Hradec Kralove). 2021;64:183\u20136.","journal-title":"Acta Med (Hradec Kralove)."},{"key":"3486_CR64","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10072-021-05849-0","volume":"43","author":"N Kim","year":"2022","unstructured":"Kim N, Kim J-H, Park J-S. Guillain-Barr\u00e9 syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea. Neurol Sci. 2022;43:1491\u20133.","journal-title":"Neurol Sci."},{"key":"3486_CR65","doi-asserted-by":"publisher","first-page":"2329048X2210745","DOI":"10.1177\/2329048X221074549","volume":"9","author":"Y Kim","year":"2022","unstructured":"Kim Y, et al. A pediatric case of sensory predominant Guillain-Barr\u00e9 syndrome following COVID-19 vaccination. Child Neurol Open. 2022;9:2329048X221074549.","journal-title":"Child Neurol Open."},{"key":"3486_CR66","doi-asserted-by":"publisher","first-page":"e01226","DOI":"10.1016\/j.idcr.2021.e01226","volume":"25","author":"J Finsterer","year":"2021","unstructured":"Finsterer J. Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination. IDCases. 2021;25:e01226.","journal-title":"IDCases."},{"key":"3486_CR67","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.neurol.2021.04.005","volume":"177","author":"J Theuriet","year":"2021","unstructured":"Theuriet J, et al. Guillain-Barr\u00e9 syndrome following first injection of ChAdOx1 nCoV-19 vaccine: first report. Rev Neurol (Paris). 2021;177:1305\u20137.","journal-title":"Rev Neurol (Paris)."},{"key":"3486_CR68","doi-asserted-by":"publisher","first-page":"2125753","DOI":"10.1080\/21645515.2022.2125753","volume":"18","author":"H Liang","year":"2022","unstructured":"Liang H, et al. Miller-fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: case report and scope review. Hum Vaccines Immunother. 2022;18:2125753.","journal-title":"Hum Vaccines Immunother."},{"key":"3486_CR69","doi-asserted-by":"publisher","first-page":"102540","DOI":"10.1016\/j.amsu.2021.102540","volume":"67","author":"A Razok","year":"2021","unstructured":"Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar. Ann Med Surg. 2021;67:102540.","journal-title":"Ann Med Surg."},{"key":"3486_CR70","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.26144","volume":"90","author":"CM Allen","year":"2021","unstructured":"Allen CM, et al. Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. 2021;90:315\u20138.","journal-title":"Ann Neurol."},{"key":"3486_CR71","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s13760-021-01798-9","volume":"122","author":"F Bax","year":"2022","unstructured":"Bax F, Gigli GL, Belgrado E, Brunelli L, Valente M. Guillain-Barr\u00e9 syndrome following Covid-19 immunization: a report of two cases. Acta Neurol Belg. 2022;122:1365\u20137.","journal-title":"Acta Neurol Belg."},{"key":"3486_CR72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/jnnp-2021-327027","volume":"93","author":"GB Bonifacio","year":"2022","unstructured":"Bonifacio GB, et al. Bilateral facial weakness with paraesthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg Psychiatry. 2022;93:341\u20132.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"3486_CR73","doi-asserted-by":"publisher","first-page":"577691","DOI":"10.1016\/j.jneuroim.2021.577691","volume":"359","author":"YG Min","year":"2021","unstructured":"Min YG, et al. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature. J Neuroimmunol. 2021;359:577691.","journal-title":"J Neuroimmunol."},{"key":"3486_CR74","doi-asserted-by":"publisher","first-page":"120330","DOI":"10.1016\/j.jns.2022.120330","volume":"440","author":"F Germano","year":"2022","unstructured":"Germano F, et al. COVID-19 vaccine-related Guillain-Barr\u00e9 syndrome in the Liguria region of Italy: A multicenter case series. J Neurol Sci. 2022;440:120330.","journal-title":"J Neurol Sci."},{"key":"3486_CR75","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3855\/jidc.16998","volume":"16","author":"PD Hai","year":"2022","unstructured":"Hai PD, et al. Guillain-Barr\u00e9 syndrome after COVID-19 vaccination: report of two cases from Vietnam. J Infect Dev Ctries. 2022;16:1703\u20135.","journal-title":"J Infect Dev Ctries."},{"key":"3486_CR76","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bcp.15601","volume":"89","author":"K Berrim","year":"2023","unstructured":"Berrim K, et al. Guillain-Barr\u00e9 syndrome after COVID-19 vaccines: A Tunisian case series. Br J Clin Pharmacol. 2023;89:574\u20138.","journal-title":"Br J Clin Pharmacol."},{"key":"3486_CR77","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/CND.0000000000000396","volume":"24","author":"J James","year":"2022","unstructured":"James J, Johnson J, Jose J. Neuralgic Amyotrophy after ChAdOx1 nCoV-19 COVID-19 vaccination. J Clin Neuromuscul Dis. 2022;24:112\u20133.","journal-title":"J Clin Neuromuscul Dis."},{"key":"3486_CR78","doi-asserted-by":"publisher","first-page":"e244527","DOI":"10.1136\/bcr-2021-244527","volume":"14","author":"G Kanabar","year":"2021","unstructured":"Kanabar G, Wilkinson P. Guillain-Barr\u00e9 syndrome presenting with facial diplegia following COVID-19 vaccination in two patients. BMJ Case Rep. 2021;14:e244527.","journal-title":"BMJ Case Rep."},{"key":"3486_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.32598\/bcn.2021.3565.1","volume":"12","author":"N Karimi","year":"2021","unstructured":"Karimi N, et al. Guillain-Barre syndrome and COVID-19 vaccine: A report of nine patients. Basic Clin Neurosci. 2021;12:703\u201310.","journal-title":"Basic Clin Neurosci."},{"key":"3486_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(21)00416-6","volume":"21","author":"JY Chun","year":"2022","unstructured":"Chun JY, et al. Guillain-Barr\u00e9 syndrome after vaccination against COVID-19. Lancet Neurol. 2022;21:117\u20139.","journal-title":"Lancet Neurol"},{"key":"3486_CR81","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nmd.2022.05.003","volume":"32","author":"JI Castiglione","year":"2022","unstructured":"Castiglione JI, et al. Bilateral facial palsy with paresthesias, variant of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine: A case series of 9 patients. Neuromuscul Disord NMD. 2022;32:572\u20134.","journal-title":"Neuromuscul Disord NMD."},{"key":"3486_CR82","first-page":"e30888","volume":"14","author":"G Nagdev","year":"2022","unstructured":"Nagdev G, Chavan G, Sahu G, Devasilpa Raju PD. COVID-19 vaccination a cause of Guillain-Barr\u00e9 syndrome? A Case Series. Cureus. 2022;14:e30888.","journal-title":"Cureus."},{"key":"3486_CR83","doi-asserted-by":"publisher","first-page":"2045153","DOI":"10.1080\/21645515.2022.2045153","volume":"18","author":"S Tabatabaee","year":"2022","unstructured":"Tabatabaee S, et al. Post COVID-19 vaccination Guillain-Barre syndrome: three cases. Hum Vaccines Immunother. 2022;18:2045153.","journal-title":"Hum Vaccines Immunother."},{"key":"3486_CR84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1212\/CPJ.0000000000001148","volume":"12","author":"MM Wan","year":"2022","unstructured":"Wan MM, Lee A, Kapadia R, Hahn C. Case series of Guillain-Barr\u00e9 syndrome after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Neurol Clin Pract. 2022;12:149\u201353.","journal-title":"Neurol Clin Pract."},{"key":"3486_CR85","doi-asserted-by":"publisher","first-page":"577719","DOI":"10.1016\/j.jneuroim.2021.577719","volume":"360","author":"WM Oo","year":"2021","unstructured":"Oo WM, Giri P, de Souza A. AstraZeneca COVID-19 vaccine and Guillain- Barr\u00e9 syndrome in Tasmania: A causal link? J Neuroimmunol. 2021;360:577719.","journal-title":"J Neuroimmunol."},{"key":"3486_CR86","doi-asserted-by":"publisher","first-page":"108818","DOI":"10.1016\/j.clim.2021.108818","volume":"230","author":"M Garc\u00eda-Grimshaw","year":"2021","unstructured":"Garc\u00eda-Grimshaw M, et al. Guillain-Barr\u00e9 syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol. 2021;230:108818.","journal-title":"Clin Immunol."},{"key":"3486_CR87","doi-asserted-by":"publisher","first-page":"820723","DOI":"10.3389\/fneur.2021.820723","volume":"12","author":"J-E Kim","year":"2021","unstructured":"Kim J-E, et al. Guillain-Barr\u00e9 syndrome and variants following COVID-19 vaccination: report of 13 cases. Front Neurol. 2021;12:820723.","journal-title":"Front Neurol."},{"key":"3486_CR88","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.3346\/jkms.2022.37.e58","volume":"37","author":"JW Kim","year":"2022","unstructured":"Kim JW, et al. Guillain-Barre syndrome after two COVID-19 vaccinations: two case reports with follow-up Electrodiagnostic study. J Korean Med Sci. 2022;37:e58.","journal-title":"J Korean Med Sci."},{"key":"3486_CR89","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26218","volume":"90","author":"J Osowicki","year":"2021","unstructured":"Osowicki J, et al. Guillain-Barr\u00e9 syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV \u22122 vaccines. Ann Neurol. 2021;90:856\u20138.","journal-title":"Ann Neurol."},{"key":"3486_CR90","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ana.26143","volume":"90","author":"BV Maramattom","year":"2021","unstructured":"Maramattom BV, et al. Guillain-Barr\u00e9 syndrome following ChAdOx1-S \/ nCoV \u221219 vaccine. Ann Neurol. 2021;90:312\u20134.","journal-title":"Ann Neurol."},{"key":"3486_CR91","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000521462","volume":"14","author":"LBE Shields","year":"2022","unstructured":"Shields LBE, Iyer VG, Zhang YP, Burger JT, Shields CB. Parsonage-turner syndrome following COVID-19 vaccination: clinical and Electromyographic findings in 6 patients. Case Rep Neurol. 2022;14:58\u201367.","journal-title":"Case Rep Neurol."},{"key":"3486_CR92","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1148\/radiol.2021211374","volume":"302","author":"SC Queler","year":"2022","unstructured":"Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB. Parsonage-turner syndrome following COVID-19 vaccination: MR Neurography. Radiology. 2022;302:84\u20137.","journal-title":"Radiology."},{"key":"3486_CR93","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1136\/jnnp-2021-328182","volume":"93","author":"YG Min","year":"2022","unstructured":"Min YG, et al. Parsonage-turner syndrome following COVID-19 vaccination. J Neurol Neurosurg Psychiatry. 2022;93:1231\u20132.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"3486_CR94","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/qjmed\/hcab216","volume":"114","author":"JS Koh","year":"2021","unstructured":"Koh JS, et al. Neuralgic amyotrophy following COVID-19 mRNA vaccination. QJM Int J Med. 2021;114:503\u20135.","journal-title":"QJM Int J Med."},{"key":"3486_CR95","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s13256-021-03176-8","volume":"15","author":"BK Vitturi","year":"2021","unstructured":"Vitturi BK, et al. Parsonage-turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature. J Med Case Rep. 2021;15:589.","journal-title":"J Med Case Rep."},{"key":"3486_CR96","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4103\/aian.aian_354_22","volume":"25","author":"R Sharma","year":"2022","unstructured":"Sharma R, Dua B, Goyal S, Tiwari T. Parsonage\u2013Turner Syndrome Following COVID-19 Vaccine. Ann Indian Acad Neurol. 2022;25:973\u20135.","journal-title":"Ann Indian Acad Neurol."},{"key":"3486_CR97","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5606\/tftrd.2022.10456","volume":"68","author":"A \u00d6ncel","year":"2022","unstructured":"\u00d6ncel A, Co\u015fkun E. Parsonage-turner syndrome after SARS-CoV-2 vaccination: A case report. Turk J Phys Med Rehabil. 2022;68:418\u201321.","journal-title":"Turk J Phys Med Rehabil."},{"key":"3486_CR98","doi-asserted-by":"publisher","first-page":"e6483","DOI":"10.1002\/ccr3.6483","volume":"10","author":"I Mejri","year":"2022","unstructured":"Mejri I, et al. Parsonage-turner syndrome of the brachial plexus secondary to COVID-19 vaccine: A case report. Clin Case Rep. 2022;10:e6483.","journal-title":"Clin Case Rep."},{"key":"3486_CR99","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1002\/mus.27255","volume":"64","author":"S Mahajan","year":"2021","unstructured":"Mahajan S, Zhang F, Mahajan A, Zimnowodzki S. Parsonage turner syndrome after COVID-19 vaccination. Muscle Nerve. 2021;64:E3\u20134.","journal-title":"Muscle Nerve."},{"key":"3486_CR100","first-page":"e27867","volume":"14","author":"M Lakkireddy","year":"2022","unstructured":"Lakkireddy M, Sathu S, Kumar R, Madhu Latha K, Maley DK. Parsonage-turner syndrome following Covishield (AstraZeneca ChAdOx1 nCoV-19) vaccination: A case report. Cureus. 2022;14:e27867.","journal-title":"Cureus."},{"key":"3486_CR101","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2022.11.014","volume":"140","author":"K Fukahori","year":"2022","unstructured":"Fukahori K, et al. Neuralgic Amyotrophy after COVID-19 vaccination in an adolescent: successful intravenous immunoglobulin treatment. Pediatr Neurol. 2022;140:50\u20131.","journal-title":"Pediatr Neurol."},{"key":"3486_CR102","first-page":"e25493","volume":"14","author":"MA Amjad","year":"2022","unstructured":"Amjad MA, et al. COVID-19 vaccine-induced parsonage-turner syndrome: A case report and literature review. Cureus. 2022;14:e25493.","journal-title":"Cureus."},{"key":"3486_CR103","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/CND.0000000000000411","volume":"23","author":"JH Bernheimer","year":"2022","unstructured":"Bernheimer JH, Gasbarro G. Parsonage turner syndrome following vaccination with mRNA-1273 SARS-CoV-2 vaccine. J Clin Neuromuscul Dis. 2022;23:229\u201330.","journal-title":"J Clin Neuromuscul Dis."},{"key":"3486_CR104","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1007\/s10072-022-06004-z","volume":"43","author":"C Civardi","year":"2022","unstructured":"Civardi C, Delconte C, Pisano F, Collini A, Geda C. Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination. Neurol Sci. 2022;43:3515\u20137.","journal-title":"Neurol Sci."},{"key":"3486_CR105","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/pmrj.12619","volume":"14","author":"N Diaz-Segarra","year":"2022","unstructured":"Diaz-Segarra N, et al. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: A case report. PM R. 2022;14:889\u201391.","journal-title":"PM R."},{"key":"3486_CR106","first-page":"571","volume":"36","author":"JA Crespo Burillo","year":"2021","unstructured":"Crespo Burillo JA, Loriente Mart\u00ednez C, Garc\u00eda Arguedas C, Mora Pueyo FJ. Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurol Engl Ed. 2021;36:571\u20132.","journal-title":"Neurol Engl Ed."},{"key":"3486_CR107","doi-asserted-by":"publisher","unstructured":"Coffman JR, Randolph AC, Somerson JS. Parsonage-Turner Syndrome After SARS-CoV-2 BNT162b2 Vaccine: A Case Report. JBJS Case Connector. 2021;11(3):e21.00370.\u00a0https:\/\/doi.org\/10.2106\/JBJS.CC.21.00370.","DOI":"10.2106\/JBJS.CC.21.00370"},{"key":"3486_CR108","doi-asserted-by":"publisher","unstructured":"Flikkema K, Brossy K. Parsonage-Turner Syndrome After COVID-19 Vaccination: A Case Report. JBJS Case Connect. 2021;11(4):e21.00577.\u00a0https:\/\/doi.org\/10.2106\/JBJS.CC.21.00577.","DOI":"10.2106\/JBJS.CC.21.00577"},{"key":"3486_CR109","doi-asserted-by":"publisher","first-page":"030006052110567","DOI":"10.1177\/03000605211056783","volume":"49","author":"SI Kim","year":"2021","unstructured":"Kim SI, Seok HY, Yi J, Cho JH. Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: a case report. J Int Med Res. 2021;49:030006052110567.","journal-title":"J Int Med Res."},{"key":"3486_CR110","doi-asserted-by":"publisher","first-page":"152","DOI":"10.25259\/SNI_4_2022","volume":"13","author":"MMJ Chua","year":"2022","unstructured":"Chua MMJ, Hayes MT, Cosgrove R. Parsonage-turner syndrome following COVID-19 vaccination and review of the literature. Surg Neurol Int. 2022;13:152.","journal-title":"Surg Neurol Int."},{"key":"3486_CR111","doi-asserted-by":"publisher","first-page":"e05468","DOI":"10.1002\/ccr3.5468","volume":"10","author":"O Mirmosayyeb","year":"2022","unstructured":"Mirmosayyeb O, Barzegar M, Rezaei M, Baharlouie N, Shaygannejad V. Bell\u2019s palsy after sputnik V COVID-19 (gam-COVID-Vac) vaccination. Clin Case Rep. 2022;10:e05468.","journal-title":"Clin Case Rep."},{"key":"3486_CR112","doi-asserted-by":"crossref","unstructured":"SALBA\u015e E, \u00d6CEK \u00d6, \u00d6CEK L, KARAHAN AY. Letter to the Editor: Facial paralysis following messenger RNA COVID-19 Vaccines: The report of two Cases. Ege T\u0131p Bilimleri Dergisi. 2021;4(2):73\u20137.","DOI":"10.33713\/egetbd.969419"},{"key":"3486_CR113","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.bbih.2021.100217","volume":"13","author":"M Repajic","year":"2021","unstructured":"Repajic M, Lai XL, Xu P, Liu A. Bell\u2019s palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy. Brain Behav Immun \u2013 Health. 2021;13:100217.","journal-title":"Brain Behav Immun \u2013 Health."},{"key":"3486_CR114","doi-asserted-by":"publisher","unstructured":"Poudel S, Nepali P, Baniya S, Shah S, Bogati S, Nepal G, Ojha R, Edaki O, Lazovic G, Kara S. Bell's palsy as a possible complication of mRNA-1273 (Moderna) vaccine against COVID-19. Ann Med Surg (Lond). 2022;78:103897. https:\/\/doi.org\/10.1016\/j.amsu.2022.103897.","DOI":"10.1016\/j.amsu.2022.103897"},{"key":"3486_CR115","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1007\/s00415-021-10462-4","volume":"268","author":"G Colella","year":"2021","unstructured":"Colella G, Orlandi M, Cirillo N. Bell\u2019s palsy following COVID-19 vaccination. J Neurol. 2021;268:3589\u201391.","journal-title":"J Neurol."},{"key":"3486_CR116","first-page":"298","volume":"28","author":"S Pothiawala","year":"2021","unstructured":"Pothiawala S. Bell\u2019s palsy after second dose of Moderna COVID-19 vaccine: coincidence or causation? Acta Medica Litu. 2021;28:298\u2013301.","journal-title":"Acta Medica Litu."},{"key":"3486_CR117","first-page":"e15935","volume":"13","author":"H Iftikhar","year":"2021","unstructured":"Iftikhar H, Noor SMU, Masood M, Bashir K. Bell\u2019s palsy after 24 hours of mRNA-1273 SARS-CoV-2 vaccine. Cureus. 2021;13:e15935.","journal-title":"Cureus."},{"key":"3486_CR118","first-page":"e27422","volume":"14","author":"H Zhang","year":"2022","unstructured":"Zhang H, Sanchez Gomez D, Repajic M, Liu AK. Another case of Bell\u2019s palsy recurrence after Pfizer-BioNTech COVID-19 vaccination. Cureus. 2022;14:e27422.","journal-title":"Cureus"},{"issue":"9","key":"3486_CR119","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/qjmed\/hcab143","volume":"114","author":"Y Nishizawa","year":"2021","unstructured":"Nishizawa Y, Hoshina Y, Baker V. Bell\u2019s palsy following the Ad26.COV2.S COVID-19 vaccination. QJM Int J Med. 2021;114(9):657\u20138. https:\/\/doi.org\/10.1093\/qjmed\/hcab143.","journal-title":"QJM Int J Med."},{"key":"3486_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinimag.2021.10.010","volume":"82","author":"M Cellina","year":"2022","unstructured":"Cellina M, D\u2019Arrigo A, Floridi C, Oliva G, Carrafiello G. Left Bell\u2019s palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A case report. Clin Imaging. 2022;82:1\u20134.","journal-title":"Clin Imaging."},{"key":"3486_CR121","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00415-021-10617-3","volume":"269","author":"C Martin-Villares","year":"2022","unstructured":"Martin-Villares C, Vazquez-Feito A, Gonzalez-Gimeno MJ, de la Nogal-Fernandez B. Bell\u2019s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. J Neurol. 2022;269:47\u20138.","journal-title":"J Neurol."},{"key":"3486_CR122","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s10072-021-05496-5","volume":"42","author":"M Obermann","year":"2021","unstructured":"Obermann M, Krasniqi M, Ewers N, Fayad J, Haeberle U. Bell\u2019s palsy following COVID-19 vaccination with high CSF antibody response. Neurol Sci. 2021;42:4397\u20139.","journal-title":"Neurol Sci."},{"key":"3486_CR123","doi-asserted-by":"publisher","first-page":"8274","DOI":"10.12998\/wjcc.v9.i27.8274","volume":"9","author":"B-Y Yu","year":"2021","unstructured":"Yu B-Y, Cen L-S, Chen T, Yang T-H. Bell\u2019s palsy after inactivated COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy: A case report. World J Clin Cases. 2021;9:8274\u20139.","journal-title":"World J Clin Cases."},{"key":"3486_CR124","doi-asserted-by":"publisher","first-page":"e243829","DOI":"10.1136\/bcr-2021-243829","volume":"14","author":"A Burrows","year":"2021","unstructured":"Burrows A, Bartholomew T, Rudd J, Walker D. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Rep. 2021;14:e243829.","journal-title":"BMJ Case Rep."},{"key":"3486_CR125","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4103\/ijo.IJO_2425_21","volume":"70","author":"S Ish","year":"2022","unstructured":"Ish S, Ish P. Isolated peripheral facial nerve palsy post COVID-19 vaccination with complete clinical recovery. Indian J Ophthalmol. 2022;70:347.","journal-title":"Indian J Ophthalmol."},{"key":"3486_CR126","unstructured":"Galimi R, Galimi M. Adverse Event Reporting after mRNA COVID-19 Vaccination: A Bell\u2019s Palsy Case the Day after. Neurol Case Rep. 2021;4(2):1026."},{"key":"3486_CR127","doi-asserted-by":"publisher","first-page":"101259","DOI":"10.1016\/j.ajoc.2022.101259","volume":"25","author":"CC Mussatto","year":"2022","unstructured":"Mussatto CC, Sokol J, Alapati N. Bell\u2019s palsy following COVID-19 vaccine administration in HIV+ patient. Am J Ophthalmol Case Rep. 2022;25:101259.","journal-title":"Am J Ophthalmol Case Rep."},{"key":"3486_CR128","first-page":"e25969","volume":"14","author":"F Khokhar","year":"2022","unstructured":"Khokhar F, Khan A, Hussain Z, Yu J. Small Fiber neuropathy associated with the Moderna SARS-CoV-2 vaccine. Cureus. 2022;14:e25969.","journal-title":"Cureus."},{"key":"3486_CR129","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mus.27251","volume":"64","author":"W Waheed","year":"2021","unstructured":"Waheed W, Carey ME, Tandan SR, Tandan R. Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve. 2021;64:E1\u20132.","journal-title":"Muscle Nerve."},{"key":"3486_CR130","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.4103\/jfmpc.jfmpc_2394_21","volume":"11","author":"J Finsterer","year":"2022","unstructured":"Finsterer J. Small fiber neuropathy as a complication of SARS-CoV-2 vaccinations. J Fam Med Prim Care. 2022;11:4071.","journal-title":"J Fam Med Prim Care."},{"key":"3486_CR131","first-page":"e16791","volume":"13","author":"TY Chuang","year":"2021","unstructured":"Chuang TY, Burda K, Teklemariam E, Athar K. Tolosa-hunt syndrome presenting after COVID-19 vaccination. Cureus. 2021;13:e16791.","journal-title":"Cureus."},{"key":"3486_CR132","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.1007\/s10072-022-06284-5","volume":"43","author":"G Fanella","year":"2022","unstructured":"Fanella G, et al. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series. Neurol Sci. 2022;43:5799\u2013802.","journal-title":"Neurol Sci."},{"key":"3486_CR133","doi-asserted-by":"publisher","unstructured":"Ramdas S, et al. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature. Neuromuscul Disord. 2022;S0960896622006502 https:\/\/doi.org\/10.1016\/j.nmd.2022.09.001.","DOI":"10.1016\/j.nmd.2022.09.001"},{"key":"3486_CR134","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3988\/jcn.2022.18.6.681","volume":"18","author":"R Devaraj","year":"2022","unstructured":"Devaraj R, Shafi P, Nagesh C, Naidu A, Satishchandra P. Spectrum of neurological complications following COVID-19 vaccination in India. J Clin Neurol Seoul Korea. 2022;18:681\u201391.","journal-title":"J Clin Neurol Seoul Korea."},{"key":"3486_CR135","doi-asserted-by":"publisher","unstructured":"Abicic A, Sitas B, Adamec I, Bilic E, Habek M. New-onset ocular myasthenia gravis after booster dose of COVID-19 vaccine. Cureus. 2022; https:\/\/doi.org\/10.7759\/cureus.27213.","DOI":"10.7759\/cureus.27213"},{"key":"3486_CR136","doi-asserted-by":"publisher","first-page":"215013272110519","DOI":"10.1177\/21501327211051933","volume":"12","author":"A Chavez","year":"2021","unstructured":"Chavez A, Pougnier C. A case of COVID-19 vaccine associated new diagnosis myasthenia gravis. J Prim Care Community Health. 2021;12:215013272110519.","journal-title":"J Prim Care Community Health."},{"key":"3486_CR137","doi-asserted-by":"publisher","unstructured":"Hoshina Y, Sowers C, Baker V. Myasthenia gravis presenting after administration of the mRNA-1273 vaccine. Eur J Case Rep Intern Med. 2022;1 https:\/\/doi.org\/10.12890\/2022_003439.","DOI":"10.12890\/2022_003439"},{"key":"3486_CR138","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.ajoc.2022.101620","volume":"27","author":"MC Kang","year":"2022","unstructured":"Kang MC, Park K-A, Min J-H, Oh SY. Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report. Am J Ophthalmol Case Rep. 2022;27:101620.","journal-title":"Am J Ophthalmol Case Rep."},{"key":"3486_CR139","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.3346\/jkms.2022.37.e50","volume":"37","author":"MA Lee","year":"2022","unstructured":"Lee MA, Lee C, Park JH, Lee JH. Early-onset myasthenia gravis following COVID-19 vaccination. J Korean Med Sci. 2022;37:e50.","journal-title":"J Korean Med Sci."},{"key":"3486_CR140","doi-asserted-by":"publisher","unstructured":"Slavin E, Fitzig J, Neubert C, Garcia-Lopez F, Cuevas-Trisan R. New-Onset Myasthenia Gravis Confirmed by Electrodiagnostic Studies After a Third Dose of SARS-CoV-2 mRNA-1273 Vaccine. Am J Phys Med Rehabil. 2022;101(12):e176-9.\u00a0https:\/\/doi.org\/10.1097\/PHM.0000000000002076.","DOI":"10.1097\/PHM.0000000000002076"},{"key":"3486_CR141","doi-asserted-by":"publisher","unstructured":"Maher DI, Hogarty D, Ben Artsi E. Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine. Orbit. 2022;1\u20135 https:\/\/doi.org\/10.1080\/01676830.2022.2062777.","DOI":"10.1080\/01676830.2022.2062777"},{"key":"3486_CR142","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s13760-021-01612-6","volume":"121","author":"G Galassi","year":"2021","unstructured":"Galassi G, Marchioni A. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay. Acta Neurol Belg. 2021;121:633\u201342.","journal-title":"Acta Neurol Belg."},{"key":"3486_CR143","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/ijerph20010467","volume":"20","author":"E Virgilio","year":"2022","unstructured":"Virgilio E, Tondo G, Montabone C, Comi C. COVID-19 vaccination and late-onset myasthenia gravis: A new case report and review of the literature. Int J Environ Res Public Health. 2022;20:467.","journal-title":"Int J Environ Res Public Health."},{"key":"3486_CR144","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mus.26328","volume":"59","author":"L Davalos","year":"2019","unstructured":"Davalos L, Kushlaf H. New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette-Guerin treatment for bladder cancer: A case study. Muscle Nerve. 2019;59:E1\u20132.","journal-title":"Muscle Nerve."},{"key":"3486_CR145","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12883-018-1233-y","volume":"18","author":"JY Chung","year":"2018","unstructured":"Chung JY, Lee SJ, Shin B-S, Kang HG. Myasthenia gravis following human papillomavirus vaccination: a case report. BMC Neurol. 2018;18:222.","journal-title":"BMC Neurol."},{"key":"3486_CR146","doi-asserted-by":"publisher","first-page":"e8757","DOI":"10.1097\/MD.0000000000008757","volume":"96","author":"T Takizawa","year":"2017","unstructured":"Takizawa T, et al. New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review. Medicine (Baltimore). 2017;96:e8757.","journal-title":"Medicine (Baltimore)."},{"key":"3486_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2010.02.016","volume":"292","author":"J-P St\u00fcbgen","year":"2010","unstructured":"St\u00fcbgen J-P. Neuromuscular disorders associated with hepatitis B vaccination. J Neurol Sci. 2010;292:1\u20134.","journal-title":"J Neurol Sci."},{"key":"3486_CR148","doi-asserted-by":"publisher","first-page":"782198","DOI":"10.3389\/fimmu.2022.782198","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F, et al. Population-based incidence of Guillain-Barr\u00e9 syndrome during mass immunization with viral vaccines: A pooled analysis. Front Immunol. 2022;13:782198.","journal-title":"Front Immunol."},{"key":"3486_CR149","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/fampra\/cmab068","volume":"39","author":"S Ahsanuddin","year":"2022","unstructured":"Ahsanuddin S, Nasser W, Roy SC, Povolotskiy R, Paskhover B. Facial paralysis and vaccinations: a vaccine adverse event reporting system review. Fam Pract. 2022;39:80\u20134.","journal-title":"Fam Pract."},{"key":"3486_CR150","doi-asserted-by":"crossref","unstructured":"Sanghani N, Rajanigandhi H, Shreya S, Nizar S. \u201cMyasthenia Gravis after Vaccination in Adults the United States: A Report from the CDC\/FDA Vaccine Adverse Event Reporting System (1990\u20132017) (P6.437).\u201d Neurology. 2018;90.","DOI":"10.1212\/WNL.90.15_supplement.P6.437"},{"key":"3486_CR151","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s12026-022-09316-6","volume":"70","author":"M Abolmaali","year":"2022","unstructured":"Abolmaali M, et al. Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review. Immunol Res. 2022;70:752\u201364.","journal-title":"Immunol Res."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-023-03486-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-023-03486-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T20:02:44Z","timestamp":1702411364000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-023-03486-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":151,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3486"],"URL":"https:\/\/doi.org\/10.1186\/s12883-023-03486-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3278253\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"19 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}